Literature DB >> 23203967

Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries.

Lawan Siangjong1, Kathryn M Gauthier, Sandra L Pfister, Emer M Smyth, William B Campbell.   

Abstract

Arachidonic acid (AA) metabolites mediate endothelium-dependent relaxation in many vascular beds. Previously, we identified the major AA 12/15-lipoxygenase (12/15-LO) metabolite of mouse arteries as 12-hydroxyeicosatetraenoic acid (12-HETE). The goal was to determine the stereospecific configuration of mouse vascular 12-HETE and characterize the role of 12-HETE stereoisomers in the regulation of vascular tone. Using normal, reverse phase, and chiral HPLC, the stereospecific configuration was identified as 12(S)-HETE. 12(S)-HETE relaxed U46619-, carbocyclic thromboxane A(2)-, PGF(2α)-, and 8-iso PGF(2α)-preconstricted mesenteric arteries, but not phenylephrine-preconstricted arteries. 12(R)-HETE was more potent than 12(S)-HETE in relaxing U46619-preconstricted mouse arteries (maximum relaxations = 91.4 ± 2.7% and 71.8 ± 5.9%, respectively). Neither 12-HETE isomer caused constriction. Pretreatment with 12(S)- or 12(R)-HETE (1 μM) inhibited constrictions to U46619 but not phenylephrine. To investigate the role of thromboxane A(2) (TP) receptors in 12-HETE vascular actions, [(3)H]SQ29548 radioligand binding studies were performed in mouse platelets. U46619, 12(R)-HETE, and 12(S)-HETE displaced [(3)H]SQ29548 binding with IC(50)s of 0.07, 0.32, and 1.73 μM, respectively. Both 12(S)- and 12(R)-HETE inhibited intracellular calcium increases induced by U46619 (10 nM) in HEK293 cells overexpressing TP(α) receptor (65.5% and 45.1%, respectively) and coexpressing prostacyclin (IP) and TP(α) receptors (58.0% and 27.1%, respectively). The LO inhibitor NDGA (10 μM) reduced AA relaxations in arteries preconstricted with U46619 but not phenylephrine. These results indicate that exogenous and endogenous 12(S)-HETE relax mouse mesenteric arteries that are preconstricted with thromboxane agonists. These 12(S)-HETE relaxations are mediated by TP receptor competitive inhibition and inhibition of TP agonist-induced increases in intracellular calcium.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23203967      PMCID: PMC3774504          DOI: 10.1152/ajpheart.00690.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  34 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

Review 2.  Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors.

Authors:  William B Campbell; John R Falck
Journal:  Hypertension       Date:  2007-01-02       Impact factor: 10.190

3.  Brain microvessels produce 12-hydroxyeicosatetraenoic acid.

Authors:  S A Moore; P H Figard; A A Spector; M N Hart
Journal:  J Neurochem       Date:  1989-08       Impact factor: 5.372

4.  Arachidonate dilates basilar artery by lipoxygenase-dependent mechanism and activation of K(+) channels.

Authors:  F M Faraci; C G Sobey; S Chrissobolis; D D Lund; D D Heistad; N L Weintraub
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-07       Impact factor: 3.619

5.  Interaction of 5-HETE, 12-HETE, 15-HETE and 5,12-diHETE at the human platelet thromboxane A2/prostaglandin H2 receptor.

Authors:  D E Mais; D L Saussy; D E Magee; N L Bowling
Journal:  Eicosanoids       Date:  1990

6.  Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation.

Authors:  Stephen J Wilson; Aoife M Roche; Ekaterina Kostetskaia; Emer M Smyth
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

7.  Arachidonic acid-induced vasodilation of rat small mesenteric arteries is lipoxygenase-dependent.

Authors:  Allison W Miller; Prasad V G Katakam; Hon-Chi Lee; Christina D Tulbert; David W Busija; Neal L Weintraub
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

8.  Modulation of vascular tone by 12(R)-, but not 12(S)-, hydroxyeicosatetraenoic acid.

Authors:  J Masferrer; K M Mullane
Journal:  Eur J Pharmacol       Date:  1988-07-14       Impact factor: 4.432

9.  Identification of 15-hydroxy-11,12-epoxyeicosatrienoic acid as a vasoactive 15-lipoxygenase metabolite in rabbit aorta.

Authors:  Yuttana Chawengsub; Nitin T Aggarwal; Kasem Nithipatikom; Kathryn M Gauthier; Siddam Anjaiah; Bruce D Hammock; John R Falck; William B Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-11       Impact factor: 4.733

10.  Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.

Authors:  L J Ignarro; R E Byrns; G M Buga; K S Wood
Journal:  Circ Res       Date:  1987-12       Impact factor: 17.367

View more
  9 in total

1.  Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase.

Authors:  Rebecca L Charles; Olena Rudyk; Oleksandra Prysyazhna; Alisa Kamynina; Jun Yang; Christophe Morisseau; Bruce D Hammock; Bruce A Freeman; Philip Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

2.  Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.

Authors:  Laura C Sullivan; Teresa A Chavera; Xiaoli Gao; Miryam M Pando; Kelly A Berg
Journal:  J Pharmacol Exp Ther       Date:  2017-05-02       Impact factor: 4.030

3.  12(S)-HETE mediates diabetes-induced endothelial dysfunction by activating intracellular endothelial cell TRPV1.

Authors:  Mandy Otto; Clarissa Bucher; Wantao Liu; Melanie Müller; Tobias Schmidt; Marina Kardell; Marvin Noel Driessen; Jan Rossaint; Eric R Gross; Nana-Maria Wagner
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

4.  Macrophage 12(S)-HETE Enhances Angiotensin II-Induced Contraction by a BLT2 (Leukotriene B4 Type-2 Receptor) and TP (Thromboxane Receptor)-Mediated Mechanism in Murine Arteries.

Authors:  Tamas Kriska; Anja Herrnreiter; Sandra L Pfister; Adeniyi Adebesin; John R Falck; William B Campbell
Journal:  Hypertension       Date:  2021-11-17       Impact factor: 10.190

5.  GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells.

Authors:  Sang-Kyu Park; Anja Herrnreiter; Sandra L Pfister; Kathryn M Gauthier; Benjamin A Falck; John R Falck; William B Campbell
Journal:  J Biol Chem       Date:  2018-05-18       Impact factor: 5.157

6.  Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries.

Authors:  L Siangjong; D H Goldman; T Kriska; K M Gauthier; E M Smyth; N Puli; G Kumar; J R Falck; W B Campbell
Journal:  Acta Physiol (Oxf)       Date:  2016-01-04       Impact factor: 6.311

7.  P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.

Authors:  Xuehong Liu; Catherine M Davis; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2017-04-20       Impact factor: 8.401

Review 8.  Unraveling the Role of 12- and 20- HETE in Cardiac Pathophysiology: G-Protein-Coupled Receptors, Pharmacological Inhibitors, and Transgenic Approaches.

Authors:  Jonathan V Pascale; Pamela A Lucchesi; Victor Garcia
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

9.  Arachidonic Acid Metabolite 19(S)-HETE Induces Vasorelaxation and Platelet Inhibition by Activating Prostacyclin (IP) Receptor.

Authors:  Sorin Tunaru; Ramesh Chennupati; Rolf M Nüsing; Stefan Offermanns
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.